|
2025
|
Invention
|
Binding agents having altered fc-mediated effector functions. The present invention relates to CH... |
|
2024
|
Invention
|
Polypeptide variants and uses thereof.
As described herein are polypeptides and antibodies havin... |
|
|
Invention
|
Antibody variants and uses thereof.
Described herein are polypeptides and related antibodies com... |
|
|
Invention
|
Human igg1 fc region variants and uses thereof.
Described herein are polypeptides and related an... |
|
|
Invention
|
Method for co-expression of a plurality of antibodies. The present invention relates to kits and ... |
|
2023
|
Invention
|
Anti-dr5 family antibodies, bispecific or multivalent anti-dr5 family antibodies and methods of u... |
|
2022
|
Invention
|
Antibodies capable of binding to cd27, variants thereof and uses thereof. The present invention r... |
|
|
Invention
|
Polypeptide variants and uses thereof.
Described herein are polypeptides and antibodies comprisi... |
|
|
Invention
|
Anti-death receptor antibodies and methods of use thereof.
The present invention relates to mono... |
|
2021
|
Invention
|
Antibodies and methods of use thereof in treatment of infectious disease.
The present invention ... |
|
|
Invention
|
A composition of anti-dr5 antibodies and an immunomodulatory imide drug for use in treating multi... |
|
|
Invention
|
A combination of anti-dr5 antibodies and an immunomodulatory imide drug for use in treating multi... |
|
|
Invention
|
Methods for the quantification of glycoproteins.
The invention relates to methods for the quanti... |
|
|
Invention
|
Methods for the quantification of glycoproteins. The invention relates to methods for the quantif... |
|
2020
|
Invention
|
Anti-dr5 antibodies and methods of use thereof. The present invention relates to monospecific or ... |
|
|
Invention
|
Antibody variant combinations and uses thereof.
The invention relates to combination therapy inv... |
|
|
Invention
|
Antibody variant combinations and uses thereof. The invention relates to combination therapy invo... |
|
|
Invention
|
Dimeric protein with triple mutations.
The present invention relates to dimeric proteins compris... |
|
|
Invention
|
Antibody variants and uses thereof. Described herein are polypeptides and related antibodies comp... |
|
|
Invention
|
Dosage regimens for a combination of anti-dr5 antibodies for use in treating cancer.
The present... |
|
|
Invention
|
Dosage regimens for a combination of anti-dr5 antibodies for use in treating cancer. The present ... |
|
2019
|
P/S
|
Chemical, biochemical, biological, and biotechnological, preparations, namely, antibodies, bi- an... |
|
|
P/S
|
Chemical, biochemical, biological, and biotechnological
preparations, especially antibodies, and... |
|
|
P/S
|
Chemical, biochemical, biological, and biotechnological preparations, especially antibodies, and ... |
|
|
Invention
|
Antibody variant combinations and uses thereof. Provided herein are combinations of first and sec... |
|
|
Invention
|
Polypeptide variants and uses thereof.
The present invention relates to combination therapy invo... |
|
|
Invention
|
Polypeptide variants and uses thereof. The present invention relates to combination therapy invol... |
|
2018
|
P/S
|
Chemical, biochemical, biological, and biotechnological preparations, namely, antibodies, and bi-... |
|
|
Invention
|
Therapeutic antibodies based on mutated igg hexamers.
The present invention relates to formulati... |
|
|
Invention
|
Therapeutic antibodies based on mutated igg hexamers. The present invention relates to formulatio... |
|
|
Invention
|
Polypeptide variants and uses thereof. As described herein are polypeptides and antibodies having... |
|
2017
|
Invention
|
Polypeptide variants and uses thereof. Described herein are polypeptides and antibodies comprisin... |
|
|
Invention
|
Antibodies and methods of use thereof in treatment of infectious disease. The present invention r... |
|
2016
|
Invention
|
Anti-dr5 antibodies and methods of use thereof.
The present invention relates to monospecific or... |
|
|
Invention
|
Anti-death receptor antibodies and methods of use thereof. The present invention relates to monos... |
|
2013
|
Invention
|
Dimeric protein with triple mutations. The present invention relates to dimeric proteins comprisi... |
|
|
Invention
|
Human igg1 fc region variants and uses thereof. Described herein are polypeptides and related ant... |
|
2012
|
P/S
|
Chemical, biochemical, biological, and biotechnological,
preparations, especially antibodies, bi... |
